By Julie Steenhuysen

CHICAGO (Reuters) -U.S. President Donald Trump’s embrace of an old generic drug called leucovorin for use against a rare disorder that causes autism-like symptoms has triggered a surge in demand from parents who believe it could unlock speech and social connection in their autistic children.

That has become a challenge for pediatricians and specialists who caution the science on leucovorin in people with autism is limited and does not support widespread use.

In the month since Food and Drug Administration Commissioner Marty Makary promoted the decades-old drug from GSK, saying it could help “hundreds of thousands” of children with autism, doctors and researchers say they have been inundated by parents seeking information.

“My Facebook feed is flooded with parents s

See Full Page